MAPT and Alzheimer disease: We report here the development of a new tau transgenic line (Line 1, L1) in which mice express truncated tau296–390 similar to fragment of tau isolated from AD PHFs [1] and that is targeted to the endoplasmic reticulum (ER) membrane.